Published at Aug 10, 2022 9:54 AM by etfdailynews.com mixed mixed Oppenheimer Comments on Cellectar Biosciences, Inc.’s Q1 2023 Earnings (NASDAQ:CLRB) Read Oppenheimer Comments on Cellectar Biosciences, Inc.’s Q1 2023 Earnings (NASDAQ:CLRB) at ETF Daily News CLRBCLRBZ Read more →